Prognostic implications of disappearance rate of biologic markers following radical prostatectomy
- PMID: 1700527
- DOI: 10.1016/s0090-4295(90)80287-w
Prognostic implications of disappearance rate of biologic markers following radical prostatectomy
Abstract
Six patients with localized prostatic carcinoma undergoing radical prostatectomy were studied by serial sample collection from the time of surgical removal of the prostate up to one week in the postoperative period. Of the three markers studied (PAP, PSA, LASA), half-life of specific prostatic markers were calculated. Half-life of PAP was found to be 7.25 hours +/- SE of 0.7 hours. For PSA the half-life could be obtained in 4 of 6 patients and was found to be 45.5 hours +/- SE 4.9 hours. In 2 patients PSA did not fall in a regular fashion and half-life could not be obtained. In both patients metastatic disease has developed within six months of surgery. LASA demonstrated progressive increase following surgery, most likely due to associated inflammatory reaction. These studies confirm previous observations that PSA is a more sensitive marker than PAP, and that the presence of an elevated PSA after radical prostatectomy denotes the presence of residual disease.
Similar articles
-
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.N Engl J Med. 1987 Oct 8;317(15):909-16. doi: 10.1056/NEJM198710083171501. N Engl J Med. 1987. PMID: 2442609
-
Half-life of prostate-specific antigen after radical prostatectomy: the decisive predictor of curative treatment?Eur Urol. 1992;21(3):200-5. doi: 10.1159/000474838. Eur Urol. 1992. PMID: 1379927
-
Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen.Cancer. 1996 Aug 15;78(4):809-18. doi: 10.1002/(SICI)1097-0142(19960815)78:4<809::AID-CNCR18>3.0.CO;2-Z. Cancer. 1996. PMID: 8756376
-
Tumor markers in prostate cancer.Cancer. 1992 Jul 1;70(1 Suppl):225-9. doi: 10.1002/1097-0142(19920701)70:1+<225::aid-cncr2820701309>3.0.co;2-v. Cancer. 1992. PMID: 1376192 Review.
-
Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.J Urol. 1991 May;145(5):907-23. doi: 10.1016/s0022-5347(17)38491-4. J Urol. 1991. PMID: 1707989 Review.
Cited by
-
Time course of carcinoembryonic antigen after resection of lung cancer: a predictor of recurrence.Cancer Sci. 2003 Aug;94(8):741-4. doi: 10.1111/j.1349-7006.2003.tb01512.x. Cancer Sci. 2003. PMID: 12901802 Free PMC article.
-
Prediction of tumor recurrence after radical prostatectomy using elimination kinetics of prostate-specific antigen.World J Urol. 1993;11(4):218-20. doi: 10.1007/BF00185073. World J Urol. 1993. PMID: 7508787
-
The effect of orgasm on prostate-specific antigen.World J Urol. 1994;12(6):313-5. doi: 10.1007/BF00184110. World J Urol. 1994. PMID: 7533583
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous